Jennifer Larson

4 days ago | oncologynurseadvisor.com | Jennifer Larson

The selective exportin 1 (XPO1) inhibitor selinexor (KPT-330) showed promise in improving survival rates among pediatric patients with relapsed or refractory (R/R) leukemia in a phase 1/2 study at St. Jude Children’s Research Hospital in Memphis, Tennessee (SELHEM; NCT02212561). These findings were presented by Katelyn (Purvis) Daniels, MD, at the 2025 ASPHO Conference in Louisville, Kentucky.

1 week ago | medscape.com | Jennifer Larson

About 900,000 people are affected by pulmonary embolism (PE) each year in the United States, according to the American Lung Association and about 100,000 people die each year as a result of the disorder. However, some patients diagnosed with PE may be at low risk for adverse outcomes, and some experts suggest primary care physicians (PCPs) can effectively manage these low-risk patients. According to some research, it’s both possible and feasible.

2 weeks ago | singlecare.com | Jennifer Larson

Key takeaways Atorvastatin is a prescription medication that lowers high cholesterol levels to help reduce the risk of cardiovascular disease. It is a long-acting statin. You can take it at any time of day or night. Consistency is important to maximize effectiveness.

2 weeks ago | oncologynurseadvisor.com | Jennifer Larson

Malignant vascular tumors, such as angiosarcoma, are rare among children, but pediatric patients who develop these tumors may benefit from more aggressive therapies than adults, according to a paper presented by Federico Moral Ortega, MD, of the University of Miami Sylvester Comprehensive Cancer Center in Miami, Florida, at the 2025 APSHO Conference in Louisville, Kentucky.

2 weeks ago | pulmonologyadvisor.com | Jennifer Larson

Dyspnea is a pervasive and distressing problem that affects more than 70% of patients at the time of advanced lung cancer diagnosis. A nurse-led behavioral intervention reduced the impact of dyspnea on quality of life in these patients. These study results were published in the Journal of Pain and Symptom Management.